Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308383140> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4308383140 endingPage "464" @default.
- W4308383140 startingPage "457" @default.
- W4308383140 abstract "The introduction of inhibitors of poly-(ADP-ribose) polymerase (PARP) for the treatment of women with epithelial ovarian cancers (EOC) has radically changed the treatment in maintenance setting after responding to first- and second-line chemotherapy. The aim of this paper was to assess the pharmacological costs of PARP inhibitors (olaparib, niraparib, rucaparib and veliparib) in maintenance treatment after responding to first-line chemotherapy in EOC. Incremental cost-effectiveness ratio (ICER) was calculated as the ratio between the difference of the costs in the intervention and in the control groups (pharmacy costs) and the difference between the effect in the intervention and in the control groups (progression-free survival (PFS)). We have considered the pivotal phase III randomized controlled trials (RCTs). Three different populations were considered: the overall population, patients with germline BRCA mutation (gBRCA) and homologous recombination deficiency (HRD) patients non-gBRCA mutation. Three thousand four hundred and twenty patients and 1209 patients were considered in maintenance treatment after responding to first- and second-line chemotherapy in EOC, respectively. At the actual price, the treatment with PARP inhibitors is not cost-effective in maintenance treatment after responding to first-line and second-line chemotherapy in EOC. A reduction in pharmacological costs is mandatory." @default.
- W4308383140 created "2022-11-11" @default.
- W4308383140 creator A5015393193 @default.
- W4308383140 creator A5044009241 @default.
- W4308383140 creator A5067340166 @default.
- W4308383140 creator A5084341908 @default.
- W4308383140 creator A5090671983 @default.
- W4308383140 date "2022-11-07" @default.
- W4308383140 modified "2023-10-17" @default.
- W4308383140 title "Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer" @default.
- W4308383140 cites W2049612542 @default.
- W4308383140 cites W2134119471 @default.
- W4308383140 cites W2528228811 @default.
- W4308383140 cites W2531736191 @default.
- W4308383140 cites W2621678791 @default.
- W4308383140 cites W2737389832 @default.
- W4308383140 cites W2754327139 @default.
- W4308383140 cites W2791861662 @default.
- W4308383140 cites W2802074519 @default.
- W4308383140 cites W2896705587 @default.
- W4308383140 cites W2897430921 @default.
- W4308383140 cites W2901445799 @default.
- W4308383140 cites W2923414225 @default.
- W4308383140 cites W2968650843 @default.
- W4308383140 cites W2975141952 @default.
- W4308383140 cites W2976139792 @default.
- W4308383140 cites W2994977341 @default.
- W4308383140 cites W3008326445 @default.
- W4308383140 cites W3036364440 @default.
- W4308383140 cites W3089236216 @default.
- W4308383140 cites W4226283539 @default.
- W4308383140 cites W4236289131 @default.
- W4308383140 doi "https://doi.org/10.1177/10781552221137705" @default.
- W4308383140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36344039" @default.
- W4308383140 hasPublicationYear "2022" @default.
- W4308383140 type Work @default.
- W4308383140 citedByCount "0" @default.
- W4308383140 crossrefType "journal-article" @default.
- W4308383140 hasAuthorship W4308383140A5015393193 @default.
- W4308383140 hasAuthorship W4308383140A5044009241 @default.
- W4308383140 hasAuthorship W4308383140A5067340166 @default.
- W4308383140 hasAuthorship W4308383140A5084341908 @default.
- W4308383140 hasAuthorship W4308383140A5090671983 @default.
- W4308383140 hasConcept C104317684 @default.
- W4308383140 hasConcept C121608353 @default.
- W4308383140 hasConcept C126322002 @default.
- W4308383140 hasConcept C143998085 @default.
- W4308383140 hasConcept C182979987 @default.
- W4308383140 hasConcept C2776694085 @default.
- W4308383140 hasConcept C2778283404 @default.
- W4308383140 hasConcept C2779138821 @default.
- W4308383140 hasConcept C2779962180 @default.
- W4308383140 hasConcept C2780194787 @default.
- W4308383140 hasConcept C2780427987 @default.
- W4308383140 hasConcept C2781312401 @default.
- W4308383140 hasConcept C54355233 @default.
- W4308383140 hasConcept C71924100 @default.
- W4308383140 hasConcept C82381507 @default.
- W4308383140 hasConcept C86803240 @default.
- W4308383140 hasConceptScore W4308383140C104317684 @default.
- W4308383140 hasConceptScore W4308383140C121608353 @default.
- W4308383140 hasConceptScore W4308383140C126322002 @default.
- W4308383140 hasConceptScore W4308383140C143998085 @default.
- W4308383140 hasConceptScore W4308383140C182979987 @default.
- W4308383140 hasConceptScore W4308383140C2776694085 @default.
- W4308383140 hasConceptScore W4308383140C2778283404 @default.
- W4308383140 hasConceptScore W4308383140C2779138821 @default.
- W4308383140 hasConceptScore W4308383140C2779962180 @default.
- W4308383140 hasConceptScore W4308383140C2780194787 @default.
- W4308383140 hasConceptScore W4308383140C2780427987 @default.
- W4308383140 hasConceptScore W4308383140C2781312401 @default.
- W4308383140 hasConceptScore W4308383140C54355233 @default.
- W4308383140 hasConceptScore W4308383140C71924100 @default.
- W4308383140 hasConceptScore W4308383140C82381507 @default.
- W4308383140 hasConceptScore W4308383140C86803240 @default.
- W4308383140 hasIssue "2" @default.
- W4308383140 hasLocation W43083831401 @default.
- W4308383140 hasLocation W43083831402 @default.
- W4308383140 hasOpenAccess W4308383140 @default.
- W4308383140 hasPrimaryLocation W43083831401 @default.
- W4308383140 hasRelatedWork W2345680184 @default.
- W4308383140 hasRelatedWork W2398878382 @default.
- W4308383140 hasRelatedWork W2528745864 @default.
- W4308383140 hasRelatedWork W2901011044 @default.
- W4308383140 hasRelatedWork W3015072749 @default.
- W4308383140 hasRelatedWork W3117058342 @default.
- W4308383140 hasRelatedWork W3204368990 @default.
- W4308383140 hasRelatedWork W4241586731 @default.
- W4308383140 hasRelatedWork W4283025800 @default.
- W4308383140 hasRelatedWork W4308383140 @default.
- W4308383140 hasVolume "29" @default.
- W4308383140 isParatext "false" @default.
- W4308383140 isRetracted "false" @default.
- W4308383140 workType "article" @default.